These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11498021)
41. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. Akune T; Ogata N; Hoshi K; Kubota N; Terauchi Y; Tobe K; Takagi H; Azuma Y; Kadowaki T; Nakamura K; Kawaguchi H J Cell Biol; 2002 Oct; 159(1):147-56. PubMed ID: 12379806 [TBL] [Abstract][Full Text] [Related]
42. Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes. Withers DJ; White M Endocrinology; 2000 Jun; 141(6):1917-21. PubMed ID: 10830270 [No Abstract] [Full Text] [Related]
46. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Hirayama I; Tamemoto H; Yokota H; Kubo SK; Wang J; Kuwano H; Nagamachi Y; Takeuchi T; Izumi T Diabetes; 1999 Jun; 48(6):1237-44. PubMed ID: 10342810 [TBL] [Abstract][Full Text] [Related]
47. Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes. Chuang LM; Myers MG; Seidner GA; Birnbaum MJ; White MF; Kahn CR Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5172-5. PubMed ID: 7685118 [TBL] [Abstract][Full Text] [Related]
48. Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth. Simmons JG; Ling Y; Wilkins H; Fuller CR; D'Ercole AJ; Fagin J; Lund PK Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G995-1003. PubMed ID: 17823215 [TBL] [Abstract][Full Text] [Related]
49. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. Sesti G; Federici M; Hribal ML; Lauro D; Sbraccia P; Lauro R FASEB J; 2001 Oct; 15(12):2099-111. PubMed ID: 11641236 [TBL] [Abstract][Full Text] [Related]
50. Role of IRS-2 in insulin and cytokine signalling. Sun XJ; Wang LM; Zhang Y; Yenush L; Myers MG; Glasheen E; Lane WS; Pierce JH; White MF Nature; 1995 Sep; 377(6545):173-7. PubMed ID: 7675087 [TBL] [Abstract][Full Text] [Related]
51. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328 [TBL] [Abstract][Full Text] [Related]
52. Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis. Pardini AW; Nguyen HT; Figlewicz DP; Baskin DG; Williams DL; Kim F; Schwartz MW Brain Res; 2006 Sep; 1112(1):169-78. PubMed ID: 16925984 [TBL] [Abstract][Full Text] [Related]
53. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. Hennige AM; Burks DJ; Ozcan U; Kulkarni RN; Ye J; Park S; Schubert M; Fisher TL; Dow MA; Leshan R; Zakaria M; Mossa-Basha M; White MF J Clin Invest; 2003 Nov; 112(10):1521-32. PubMed ID: 14617753 [TBL] [Abstract][Full Text] [Related]
54. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504 [TBL] [Abstract][Full Text] [Related]
55. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2. Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936 [TBL] [Abstract][Full Text] [Related]
56. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436 [TBL] [Abstract][Full Text] [Related]
57. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Yakar S; Liu JL; Fernandez AM; Wu Y; Schally AV; Frystyk J; Chernausek SD; Mejia W; Le Roith D Diabetes; 2001 May; 50(5):1110-8. PubMed ID: 11334415 [TBL] [Abstract][Full Text] [Related]
58. Insulin receptor substrates 1 and 2 but not Shc can activate the insulin receptor independent of insulin and induce proliferation in CHO-IR cells. Niessen M; Jaschinski F; Item F; McNamara MP; Spinas GA; TrĂ¼b T Exp Cell Res; 2007 Feb; 313(4):805-15. PubMed ID: 17222824 [TBL] [Abstract][Full Text] [Related]
59. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. Schubert M; Brazil DP; Burks DJ; Kushner JA; Ye J; Flint CL; Farhang-Fallah J; Dikkes P; Warot XM; Rio C; Corfas G; White MF J Neurosci; 2003 Aug; 23(18):7084-92. PubMed ID: 12904469 [TBL] [Abstract][Full Text] [Related]
60. Insulin signaling in insulin receptor substrate (IRS)-1-deficient brown adipocytes: requirement of IRS-1 for lipid synthesis. Valverde AM; Kahn CR; Benito M Diabetes; 1999 Nov; 48(11):2122-31. PubMed ID: 10535444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]